Page last updated: 2024-11-02

pentobarbital and Myotonia

pentobarbital has been researched along with Myotonia in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Myotonia: Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BECKER, RF1
BONEAU, CA1
SHEARIN, CA1
KING, JE1

Other Studies

1 other study available for pentobarbital and Myotonia

ArticleYear
BEHAVIORAL ALTERATIONS OF YOUNG RATS WITH A HISTORY OF OVERSEDATION AT BIRTH.
    Neurology, 1964, Volume: 14

    Topics: Animals, Newborn; Asphyxia Neonatorum; Female; Fetus; Guinea Pigs; Humans; Hypoxia; Infant, Newborn;

1964